Clinical Trials
3 trialsNCT04899349 2024-10-09
EPIK-B4
Novartis
Phase 2 Terminated
NCT04542291 2023-02-14
Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition
Washington University School of Medicine
Phase 1 Completed
NCT02635386 2021-01-29
EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
Woman's
Phase 3 Completed